Danone expands in Specialized Nutrition in Poland with Promedica acquisition-source
Reuters
Published Apr 11, 2023 17:05
By Dominique Vidalon
PARIS (Reuters) - French foods group Danone has bought Promedica, a Polish company specialising in care services for patients at home, as it expands in the profitable Specialized Nutrition market, a source familiar with the deal told Reuters.
The bolt-on acquisition, whose terms were not disclosed, was sealed on March 31.
It will bring more scale to Danone in Specialized Nutrition in Poland, a country where the group has already a leading position, the source said.
Danone ranks number one in Medical Nutrition in Europe and fourth worldwide.
Staff from Promedica, a profitable company with sales growing at a double-digit rate, will administer Danone products to patients needing tube feeding, the source said.
The acquisition comes as Danone, maker of high-end infant formula brands such as Aptamil and Medical Nutrition brands such as Nutricia, has embarked on a revival plan that entails investing in worthwhile brands and innovation and disposing of underperforming assets.
Homecare is a growing category as more people suffering from chronic diseases can be treated at home. It is also seen as a cost-efficient alternative to expensive hospital stays.
With 2022 revenue of 8.32 billion euros the Specialized Nutrition division made 30% of Danone's global revenue.
The division's like-for-like sales growth rate of 10% last year outperformed the group's 7.8%. Its operating profit margin of 21.6% also topped the group's 12.2%.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.